Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-17

FDA Approved: LACOSAMIDE — Original Application (Glenmark Pharmaceuticals Inc. USA)

View source ↗

Summary

The FDA approved Glenmark’s lacosamide as an original generic drug application (ANDA); lacosamide is an anticonvulsant used to treat partial-onset seizures in e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)